Top Stories
-
Esophageal Squamous Cell Carcinoma has a strong tendency to metastasize. Unfortunately, ESCC is usually diagnosed at an advanced stage, when it has an overall survival rate of only about 20 percent.
-
A new three-year, $2.5 million grant from Stand Up to Cancer (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by HICCC director Anil K. Rustgi, MD.
Topic
-
HICCC Director Anil Rustgi, MD, is being honored for his major contributions in advancing the care of patients with digestive diseases through clinical or translational research.
Topic
-
Dr. Gulam Manji presented results from a phase II clinical trial testing a combination therapy for resectable gastric cancer or gastroesophageal junction (GEJ) cancer at this year’s AACR conference.
Topic
Latest News
- April 15, 2022
Congratulations to Dr. Joel Gabre, recipient of a 2022 Research Scholar Award from the American Gastroenterological Association (AGA) Research Foundation.
Topic
- July 28, 2021
Congratulations to Ricardo Cruz-Acuña, PhD, recent recipient of the Charles H. Revson Senior Fellowship in Biomedical Science to support his work in esophageal adenocarcinoma.
Topic
- May 11, 2021
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
- April 2, 2021
In a new study, researchers from the HICCC pinpoint a new potential target in lung metastases of esophageal squamous cell carcinoma.
Topic
